Robert Gurny

Prof. Robert Gurny


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2015 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
MRMarta Rodriguez-Aller
Marta Rodriguez-Aller
SGSylvie Guinchard
Sylvie Guinchard
DGDavy Guillarme
Davy Guillarme
MPMarion Pupier
Marion Pupier
DJDamien Jeannerat
Damien Jeannerat
RGRobert Gurny
Robert Gurny

30 April 2012 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
MRM. Rodriguez-Aller
M. Rodriguez-Aller
BKB. Kaufmann
B. Kaufmann
DGD. Guillarme
D. Guillarme
CSC. Stella
C. Stella
PFP. Furrer
P. Furrer
RGRobert Gurny
Robert Gurny

1 October 2015 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
SKSema Kaderli
Sema Kaderli
EVEric Raoul VIGUIER
Eric Raoul VIGUIER
DWDorothée Watrelot-Virieux
Dorothée Watrelot-Virieux
TRThierry Roger
Thierry Roger
RGRobert Gurny
Robert Gurny
Olivier JordanOlivier Jordan
Olivier Jordan

1 June 2005 in Chimia
Verified
Journal Article
Open access
TTThomas Trimaille
Thomas Trimaille
RGRobert Gurny
Robert Gurny
MMMichael Möller
Michael Möller
Monohexyl-substituted lactide (mHLA) was synthesized by reaction of 2-hydroxyoctanoic acid with 2-bromopropionyl bromide, and polymerized with tin(II) 2-ethylhexanoate (Sn(Oct)2) or 4-dimethylaminopyridine (DMAP) in the presence of benzyl alcohol by ring-opening polymerization (ROP). Poly(monohexyl-substituted lactide) (PmHLA) of predictable molecular weights and narrow polydispersities were obtained in convenient bulk conditions at 100 °C within short polymerization times. The polymerizations were well controlled, showing a 'living' character for targeted degrees of polymerization up to DP = 60 as evidenced by molecular weight versus conversion studies and 1H NMR end group analysis. The hexyl groups have a strong impact on the glass transition temperature (Tg), which is low for PmHLA compared to standard poly(D,L-lactide) (PLA). Tg and zero shear viscosities at 25 °C can be controlled by the polymer molecular weight, ranging from ?22 °C for Mn = 2800 g/mol to ?10 °C for Mn = 9100 g/mol and 140 to 4850 Pa.s, respectively. These data are in correspondence with the Fox and Flory equations. The degradation mechanism of the PmHLA polymer in phosphate buffer pH 7.4 at 37 °C was shown to be similar to that of the standard PLA ('bulk erosion' type), with a slightly higher degradation rate, leading to the non-toxic degradation products lactic acid and 2-hydroxyoctanoic acid. PmHLA has the great potential as an alternative to conventional PLA/PLGA for drug delivery systems. By the hexyl-substitution the biodegradable PLA-ester backbone is conserved but the hydrophobicity is increased in comparison to standard PLA, while a viscous polymer is obtained. This leads to advantageous injectable solvent-free drug delivery systems, in which drugs can easily be incorporated by simple mixing.

3 December 2012 in Journal of Controlled Release
Verified
Journal Article
Closed access
LALutz R. Asmus
Lutz R. Asmus
JTJean-Christophe Tille
Jean-Christophe Tille
BKBéatrice Kaufmann
Béatrice Kaufmann
LMLouise Melander
Louise Melander
TWTorsten Weiss
Torsten Weiss
MMMichael Möller
Michael Möller

1 February 2015 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
SKS. Kaderli
S. Kaderli
CBC. Boulocher
C. Boulocher
EPE. Pillet
E. Pillet
DWD. Watrelot-Virieux
D. Watrelot-Virieux
TRT. Roger
T. Roger
MMM. Möller
M. Möller